The future of everyday healthcare is in our hands

The Re/Wire Health Studio from GSK NEXT is a collaboration platform built to improve human health.

Apply now

GSK NEXT is interested in advanced digital and biological diagnostics solutions that address consumers’ need to better understand their everyday health and take action to manage it in a positive way.

We’re inviting emerging companies that are US and/or EMEA-focused to partner with GSK NEXT in the development of

next-generation diagnostic solutions

that address

  • Digital

  • Physical

  • Personalised consumer health solutions

Are you building groundbreaking solutions for improving everyday health?

Apply for the Re/Wire Health Studio to work with us on the three areas of opportunity we’ve identified to address people’s evolving needs.

Oral Health

Our oral health directly impacts our overall well being. And yet access to oral health care—or oral health data—is far from a democratic or seamless experience.

We’re seeking solutions that…

  • Provide insight into people’s overall health by capturing and contextualising oral health data
  • Expand access to everyday dental care
  • Incentivise proactive dental care

Mental Resilience

Stress is fuel. But all too often it becomes toxic. By reframing our reaction to stress, we have the ability to transform it from toxin back to fuel.

We’re seeking solutions that…

  • Manage stress and mood
  • Improve everyday mental health monitoring by providing remote, quantitative measurement
  • Improve cognitive health through the gut-brain axis

Women’s Health & Wellness

While women typically live longer than men, they spend fewer years healthy and thriving. To improve their overall well being over the course of their lives, women need tailored solutions for every life stage.

We’re seeking solutions that…

  • Detect the risk of long-term health problems through biochemical indicators, and introduce preventive solutions
  • Identify, track, and interpret hormonal markers to better inform and guide women’s health conditions
  • Support self-care through convenient and accessible integrated solutions
Build the future of everyday healthcare with humanity.

We’ll help build the future of your business.

Why should you apply?

  • Partnership

    Collaborate with one of the largest consumer healthcare businesses to accelerate your ideas and products to market. Scale your business faster with access to a globally present corporation like GSK.

  • Curriculum

    Grow your network by exposing your business to some of the leading innovators and executives in the consumer health business.

  • Creative capital

    Access R/GA’s award-winning strategists, technologists, creatives, and consultants to hone your product offering.

Startup qualifications

  • Funding stage: pre-seed through Series A
  • Access to US and/or EMEA market
  • MVP product or service
  • Ability and eagerness to partner with GSK NEXT
Apply now

Mark your calendar

Apply now

  • May 92022

    Applications open

  • June 152022

    Applications close for Cohort 2

  • June 272022

    Candidate workshops

  • July 82022

    Cohort 2 notified

  • July 182022

    Studio begins

  • September 302022

    Final presentations

Meet our first cohort

Bristle is developing a virtual-first platform for primary oral healthcare. We leverage the oral microbiome via salivary testing to help patients understand and monitor their risk for dental caries and periodontal disease.

Bristle

Bristle’s at-home oral microbiome test measures oral health status, including risk factors for cavities, gum disease, and bad breath. Then Bristle provides personalized diet, lifestyle, and product recommendations to improve oral health and help lower risk for disease.

Health In Her HUE is a digital platform that connects Black women and women of color to culturally competent and sensitive healthcare providers, health content, and community.

Health In Her HUE

Health In Her HUE is a digital platform that connects Black women and women of color to culturally competent and sensitive healthcare providers, health content, and community.

Pioneering a New Era of Precision Neurology: AI-Powered Digital Biomarkers for Neurodegenerative Diseases" or "nQ Improves Lives by Enabling the Discovery and Development of Digital Biomarkers”

nQ Medical

nQ Medical has developed passive data collection from personal devices to address early detection of disease, with no proprietary device nor any task-based app required.

Patientory democratizes individual ownership of the world’s health data and incentives to improve health outcomes. Patientory Inc. is a population health data management and analytics company.

Patientory

Patientory’s blockchain enabled platform gathers and analyzes siloed healthcare data allowing enterprises to improve population health outcomes and employ personalized care plans that consider the entire history of the patient, including social determinants of health.

Smilo.ai is a patient engagement and virtual consultation platform that provides instant digital oral health check-ups, cosmetic consults, orthodontic assessments and treatment monitoring.

Smilo.ai

Smilo.ai is reimagining the dental care experience using AI. Their 360° end-to-end virtual care platform connects patients to dentists, with real time insights instantly and remotely.

Unfabled is the world’s first ecommerce platform for menstrual wellbeing, with a vision to own the consumer lifecycle from first period to menopause through personalised, sustainable cycle care.

Unfabled

Unfabled is the first ecommerce marketplace for menstrual wellbeing. Their platform allows people to discover sustainable wellness products personalised for their whole cycle.

About GSK NEXT

About GSK NEXT

GSK NEXT is the strategic, commercial growth engine for GSK Consumer Healthcare, focused on the creation and scaling of net-new product, service and platform businesses across everyday health.

For further information on GSK, please visit https://us.gsk.com/en-us/about-us/.

About R/GA Ventures

About R/GA Ventures

At R/GA Ventures, our mission is to work with startups and corporate partners to create a more human future.

We help corporate partners identify and capitalize on disruptive technologies and emerging behaviors, while supporting startups with financial, creative, and relationship capital to drive growth and returns.

Learn more at ventures.rga.com and by following @rgaventures.

Have questions? We have answers.

What is the mission of the Re/Wire Health Studio?

The Re/Wire Health Studio from GSK NEXT is on a mission to democratise access to everyday health care, create seamless health experiences, and improve health outcomes for consumers.

What do you mean by "everyday healthcare"?

GSK’s world-leading Consumer Healthcare business combines science and consumer insights to create innovative everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals, and supplements.

What role is GSK NEXT going to play in the Studio?

GSK NEXT will partner with participating startups to offer mentorship, R&D support, and commercialisation opportunities. The GSK NEXT team will work directly with startups and will help them navigate the resources of GSK at large.

What role is R/GA going to play in the Studio?

R/GA’s award-winning strategists, technologists, creatives, and consultants will advise the six startups selected for the Studio and prepare them for future milestones. Startups will have exposure and access to R/GA’s global client network and industry-spanning corporate partners. R/GA’s creative talent will be available to consult on startups’ presentations ahead of the presentations event at the end of the program.

Is the Re/Wire Health Studio currently accepting applications?

Yes, applications for Cohort 2 open on May 9, 2022 and close on June 15, 2022.

What type of startups is GSK NEXT looking to partner with in the Re/Wire Health Studio?

The Re/Wire Health Studio is built to collaborate with startups building next generation solutions that can address evolving consumer needs. Each focus area is aligned with core ideas surrounding everyday health issues, including proactive care. Learn more about the three focus areas of opportunity above. GSK NEXT is also interested in startups within the biomarker space both physical and biological.

If selected, what type of support will the Re/Wire Health Studio provide my company?
  • Strategic partnership opportunities – working in depth with GSK in order to facilitate opportunities for rapid global scale. These opportunities may be either commercial in market trials and partnerships or may be more R&D focused support and joint development.
  • Mentoring and networking – the studio is pulling together a panel of leaders, innovators, investors and entrepreneurs in the Consumer Health space

The Studio will identify strategic opportunities for startups to partner with GSK and provide the selected Studio companies with the market opportunities, guidance, and partnerships to build momentum towards scaling globally. Selected startups will have access to R/GA’s creative capital services with award-winning strategists, technologists, creatives, and consultants to help them develop their businesses and prepare them for future milestones.

Is my startup at the right stage to apply?

The Studio invites applications from innovative growth- and early-stage companies with disruptive technologies that will shape the future of consumer health. The Studio welcomes applications from startups with pre-seed through Series A funding.

How developed does my product or service need to be to apply to work with GSK NEXT?

GSK NEXT welcomes startups from around the world to apply but must be capable and prepared to launch in the U.S. and/or EMEA with a minimum viable product or service in development or in-market.

Will the Re/Wire Health Studio invest in my company?

Investment is not a component of the Studio; however, GSK NEXT may seek to invest in participating startups after the conclusion of the program. Participation in the program is not contingent upon the possibility of future investment, and GSK NEXT will not seek the right to invest as part of the program.

If selected to work with GSK NEXT, does my company need to relocate?

All Studio participation and programming will be done virtually. Founders are not required to relocate themselves or their team to participate.

Is there a cost to apply or participate in the Re/Wire Health Studio?

No, there is no fee or equity charge to apply or participate in the Re/Wire Health Studio.

How are final startups chosen?

The application period for the next cohort of the Re/Wire Health Studio is from May 9 through June 15, 2022. Top candidates will be invited to participate in workshops with GSK stakeholders on June 27, 2022.

Finalists will be selected based on quality of product or service (or path to product or service), robustness of business model, strength of team, and alignment with GSK NEXT’s objectives. Selected companies will go through a technical and business due diligence process.

Can I be a participant in other accelerator programs?

Participation in other accelerator programs will not exclude startups from the Re/Wire Health Studio, but preference will be given to companies that can devote the time required to pursue the full range of opportunities delivered by the Studio. Startups that have active or past partnerships or commercial engagement with competitors of GSK may not be eligible to participate.

Who is GSK?

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, and live longer. For further information please visit https://us.gsk.com/en-us/about-us/.

Who is GSK NEXT?

GSK NEXT is the strategic commercial growth engine for GSK Consumer Healthcare, focused on the creation and scaling of net-new product, service, and platform businesses across Everyday Health.

Who is R/GA?

R/GA designs businesses and brands for a more human future. A leader in technology and creativity for more than 40 years, R/GA has expanded and evolved its capabilities in anticipation of technology’s impact on its clients’ businesses to offer services through our award-winning consulting, Ventures, technology, design, communications, and IP practices.

Who is R/GA Ventures?

R/GA Ventures helps corporate leaders identify and capitalise on disruptive technologies and emerging behaviors while supporting startups with financial and creative capital to drive growth and returns. Our expertise in the startup ecosystem, coupled with our experience transforming Enterprise businesses, allows us to identify, develop, and test solutions to close the corporate innovation gap. We exist to test new products, services, and business models to fuel new waves of growth for our clients.